Date published: 2026-1-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

DAP-1 Inhibitors

DAP-1 inhibitors belong to a distinct chemical class renowned for their ability to modulate a specific enzyme involved in lipid metabolism, specifically the Dihydroxyacetone phosphate acyltransferase-1 (DAP-1) enzyme. These inhibitors are characterized by their structural attributes and functional mechanisms that enable them to interact with the active site or other critical regions of the DAP-1 enzyme, thereby impeding its enzymatic activity. The chemical structures of DAP-1 inhibitors often exhibit a diversity of organic moieties, which can include aromatic rings, aliphatic chains, heterocycles, and functional groups that enhance binding affinity to the enzyme. The inhibitors may encompass both small organic molecules and larger molecular entities, each designed with precision to effectively engage the enzyme's active site or allosteric pockets. DAP-1 inhibitors operate through a variety of inhibitory mechanisms, with some directly targeting the catalytic site of the enzyme, hindering its substrate-binding capacity or interfering with the enzymatic reaction process. Others may work indirectly by influencing the enzyme's conformational dynamics or modulating its regulatory interactions. The binding interactions between DAP-1 inhibitors and the enzyme are governed by non-covalent forces, including hydrogen bonding, van der Waals interactions, and hydrophobic interactions. These interactions collectively contribute to the stability of the inhibitor-enzyme complex, thereby attenuating the enzyme's ability to catalyze the conversion of dihydroxyacetone phosphate (DHAP) to lysophosphatidic acid (LPA) in the glycerolipid biosynthesis pathway. Structural optimization of DAP-1 inhibitors involves the iterative design and synthesis of analogs with varying chemical modifications to enhance potency, selectivity, and pharmacokinetic properties. Computational modeling, structure-activity relationship studies, and X-ray crystallography may guide the refinement of inhibitor structures. These inhibitors, once developed, serve as valuable tools for probing the biochemical functions of DAP-1 and understanding its role in cellular processes. DAP-1 inhibitors represents a significant contribution to the field of enzyme modulation and further elucidates the complex regulatory networks that govern lipid metabolism. Their intricate chemical compositions and intricate modes of action offer avenues for advancing our knowledge of enzymology and cellular biochemistry.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

A 922500

959122-11-3sc-203793
10 mg
$270.00
2
(1)

An experimental compound that inhibits DGAT1 and has shown anti-obesity effects in animal studies.

PF 04620110

1109276-89-2sc-478495
1 mg
$88.00
(0)

An experimental agent targeting DGAT1, which could have applications in obesity and metabolic disorders.